Drugs / Dilatrend SR capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01369472 | Jun → Oct 2011 | intermediate coronary syndrome | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dilatrend SR capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01369472 ↗ |
| Route | Oral | “single oral administration in period 1 or 2, 3 for each sequential group.” NCT01369472 ↗ |